A citation-based method for searching scientific literature

Yusuke Okamoto, Masako Abe, Anfeng Mu, Yasuko Tempaku, Colette B Rogers, Ayako L Mochizuki, Yoko Katsuki, Masato T Kanemaki, Akifumi Takaori-Kondo, Alexandra Sobeck, Anja-Katrin Bielinsky, Minoru Takata. Blood 2021
Times Cited: 9







List of co-cited articles
71 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


SLFN11 Blocks Stressed Replication Forks Independently of ATR.
Junko Murai, Sai-Wen Tang, Elisabetta Leo, Simone A Baechler, Christophe E Redon, Hongliang Zhang, Muthana Al Abo, Vinodh N Rajapakse, Eijiro Nakamura, Lisa M Miller Jenkins,[...]. Mol Cell 2018
120
66

Schlafen 11 (SLFN11), a restriction factor for replicative stress induced by DNA-targeting anti-cancer therapies.
Junko Murai, Anish Thomas, Markku Miettinen, Yves Pommier. Pharmacol Ther 2019
65
55

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.
Jordi Barretina, Giordano Caponigro, Nicolas Stransky, Kavitha Venkatesan, Adam A Margolin, Sungjoon Kim, Christopher J Wilson, Joseph Lehár, Gregory V Kryukov, Dmitriy Sonkin,[...]. Nature 2012
55

Putative DNA/RNA helicase Schlafen-11 (SLFN11) sensitizes cancer cells to DNA-damaging agents.
Gabriele Zoppoli, Marie Regairaz, Elisabetta Leo, William C Reinhold, Sudhir Varma, Alberto Ballestrero, James H Doroshow, Yves Pommier. Proc Natl Acad Sci U S A 2012
174
55

Codon-usage-based inhibition of HIV protein synthesis by human schlafen 11.
Manqing Li, Elaine Kao, Xia Gao, Hilary Sandig, Kirsten Limmer, Mariana Pavon-Eternod, Thomas E Jones, Sebastien Landry, Tao Pan, Matthew D Weitzman,[...]. Nature 2012
210
55

Resistance to PARP inhibitors by SLFN11 inactivation can be overcome by ATR inhibition.
Junko Murai, Ying Feng, Guoying K Yu, Yuanbin Ru, Sai-Wen Tang, Yuqiao Shen, Yves Pommier. Oncotarget 2016
158
55

Chromatin Remodeling and Immediate Early Gene Activation by SLFN11 in Response to Replication Stress.
Junko Murai, Hongliang Zhang, Lorinc Pongor, Sai-Wen Tang, Ukhyun Jo, Fumiya Moribe, Yixiao Ma, Masaru Tomita, Yves Pommier. Cell Rep 2020
22
55

DNA damage-induced cell death relies on SLFN11-dependent cleavage of distinct type II tRNAs.
Manqing Li, Elaine Kao, Dane Malone, Xia Gao, Jean Y J Wang, Michael David. Nat Struct Mol Biol 2018
45
55

SLFN11 inhibits checkpoint maintenance and homologous recombination repair.
Yanhua Mu, Jiangman Lou, Mrinal Srivastava, Bin Zhao, Xin-hua Feng, Ting Liu, Junjie Chen, Jun Huang. EMBO Rep 2016
83
44

SLFN11 promotes CDT1 degradation by CUL4 in response to replicative DNA damage, while its absence leads to synthetic lethality with ATR/CHK1 inhibitors.
Ukhyun Jo, Yasuhisa Murai, Sirisha Chakka, Lu Chen, Ken Cheng, Junko Murai, Liton Kumar Saha, Lisa M Miller Jenkins, Yves Pommier. Proc Natl Acad Sci U S A 2021
12
44

Structure of Schlafen13 reveals a new class of tRNA/rRNA- targeting RNase engaged in translational control.
Jin-Yu Yang, Xiang-Yu Deng, Yi-Sheng Li, Xian-Cai Ma, Jian-Xiong Feng, Bing Yu, Yang Chen, Yi-Ling Luo, Xi Wang, Mei-Ling Chen,[...]. Nat Commun 2018
49
44

SLFN11 informs on standard of care and novel treatments in a wide range of cancer models.
Claudia Winkler, Joshua Armenia, Gemma N Jones, Luis Tobalina, Matthew J Sale, Tudor Petreus, Tarrion Baird, Violeta Serra, Anderson T Wang, Alan Lau,[...]. Br J Cancer 2021
18
44

The first evidence for SLFN11 expression as an independent prognostic factor for patients with esophageal cancer after chemoradiotherapy.
Takuma Kagami, Mihoko Yamade, Takahiro Suzuki, Takahiro Uotani, Shinya Tani, Yasushi Hamaya, Moriya Iwaizumi, Satoshi Osawa, Ken Sugimoto, Hiroaki Miyajima,[...]. BMC Cancer 2020
11
44

SLFN11 Inactivation Induces Proteotoxic Stress and Sensitizes Cancer Cells to Ubiquitin Activating Enzyme Inhibitor TAK-243.
Yasuhisa Murai, Ukhyun Jo, Junko Murai, Lisa M Jenkins, Shar-Yin N Huang, Sirisha Chakka, Lu Chen, Ken Cheng, Shinsaku Fukuda, Naoko Takebe,[...]. Cancer Res 2021
8
50

Epigenetic inactivation of the putative DNA/RNA helicase SLFN11 in human cancer confers resistance to platinum drugs.
Vanesa Nogales, William C Reinhold, Sudhir Varma, Anna Martinez-Cardus, Catia Moutinho, Sebastian Moran, Holger Heyn, Ana Sebio, Agusti Barnadas, Yves Pommier,[...]. Oncotarget 2016
98
44

Schlafen 11 predicts response to platinum-based chemotherapy in gastric cancers.
Tsuyoshi Takashima, Daiki Taniyama, Naoya Sakamoto, Maika Yasumoto, Ryuichi Asai, Takuya Hattori, Ririno Honma, Pham Quoc Thang, Shoichi Ukai, Ryota Maruyama,[...]. Br J Cancer 2021
11
44

Chemosensitive Relapse in Small Cell Lung Cancer Proceeds through an EZH2-SLFN11 Axis.
Eric E Gardner, Benjamin H Lok, Valentina E Schneeberger, Patrice Desmeules, Linde A Miles, Paige K Arnold, Andy Ni, Inna Khodos, Elisa de Stanchina, Thuyen Nguyen,[...]. Cancer Cell 2017
237
44

Epigenetic suppression of SLFN11 in germinal center B-cells during B-cell development.
Fumiya Moribe, Momoko Nishikori, Tsuyoshi Takashima, Daiki Taniyama, Nobuyuki Onishi, Hiroshi Arima, Hiroyuki Sasanuma, Remi Akagawa, Fathi Elloumi, Shunichi Takeda,[...]. PLoS One 2021
8
37

Immunohistochemical analysis of SLFN11 expression uncovers potential non-responders to DNA-damaging agents overlooked by tissue RNA-seq.
Tsuyoshi Takashima, Naoya Sakamoto, Junko Murai, Daiki Taniyama, Ririno Honma, Shoichi Ukai, Ryota Maruyama, Kazuya Kuraoka, Vinodh N Rajapakse, Yves Pommier,[...]. Virchows Arch 2021
16
33

Schlafen 11 Restricts Flavivirus Replication.
Federico Valdez, Julienne Salvador, Pedro M Palermo, Jonathon E Mohl, Kathryn A Hanley, Douglas Watts, Manuel Llano. J Virol 2019
22
33

SLFN11 inhibits hepatocellular carcinoma tumorigenesis and metastasis by targeting RPS4X via mTOR pathway.
Chenhao Zhou, Chunxiao Liu, Wenjie Liu, Wanyong Chen, Yirui Yin, Chia-Wei Li, Jennifer L Hsu, Jialei Sun, Qiang Zhou, Hui Li,[...]. Theranostics 2020
30
33

The schlafen family of proteins and their regulation by interferons.
Evangelos Mavrommatis, Eleanor N Fish, Leonidas C Platanias. J Interferon Cytokine Res 2013
89
33

PARP Inhibitor Activity Correlates with SLFN11 Expression and Demonstrates Synergy with Temozolomide in Small Cell Lung Cancer.
Benjamin H Lok, Eric E Gardner, Valentina E Schneeberger, Andy Ni, Patrice Desmeules, Natasha Rekhtman, Elisa de Stanchina, Beverly A Teicher, Nadeem Riaz, Simon N Powell,[...]. Clin Cancer Res 2017
177
33

SLFN11 Is a Transcriptional Target of EWS-FLI1 and a Determinant of Drug Response in Ewing Sarcoma.
Sai-Wen Tang, Sven Bilke, Liang Cao, Junko Murai, Fabricio G Sousa, Mihoko Yamade, Vinodh Rajapakse, Sudhir Varma, Lee J Helman, Javed Khan,[...]. Clin Cancer Res 2015
63
33

BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers.
Florence Coussy, Rania El-Botty, Sophie Château-Joubert, Ahmed Dahmani, Elodie Montaudon, Sophie Leboucher, Ludivine Morisset, Pierre Painsec, Laura Sourd, Léa Huguet,[...]. Sci Transl Med 2020
49
33

Structure of PDE3A-SLFN12 complex reveals requirements for activation of SLFN12 RNase.
Colin W Garvie, Xiaoyun Wu, Malvina Papanastasiou, Sooncheol Lee, James Fuller, Gavin R Schnitzler, Steven W Horner, Andrew Baker, Terry Zhang, James P Mullahoo,[...]. Nat Commun 2021
10
33

Overcoming Resistance to DNA-Targeted Agents by Epigenetic Activation of Schlafen 11 (SLFN11) Expression with Class I Histone Deacetylase Inhibitors.
Sai-Wen Tang, Anish Thomas, Junko Murai, Jane B Trepel, Susan E Bates, Vinodh N Rajapakse, Yves Pommier. Clin Cancer Res 2018
43
33

Role of interferon {alpha} (IFN{alpha})-inducible Schlafen-5 in regulation of anchorage-independent growth and invasion of malignant melanoma cells.
Efstratios Katsoulidis, Evangelos Mavrommatis, Jennifer Woodard, Mario A Shields, Antonella Sassano, Nathalie Carayol, Konrad T Sawicki, Hidayatullah G Munshi, Leonidas C Platanias. J Biol Chem 2010
60
33

Formaldehyde catabolism is essential in cells deficient for the Fanconi anemia DNA-repair pathway.
Ivan V Rosado, Frédéric Langevin, Gerry P Crossan, Minoru Takata, Ketan J Patel. Nat Struct Mol Biol 2011
131
22

The essential kinase ATR: ensuring faithful duplication of a challenging genome.
Joshua C Saldivar, David Cortez, Karlene A Cimprich. Nat Rev Mol Cell Biol 2017
344
22

Non-human Primate Schlafen11 Inhibits Production of Both Host and Viral Proteins.
Alex C Stabell, John Hawkins, Manqing Li, Xia Gao, Michael David, William H Press, Sara L Sawyer. PLoS Pathog 2016
27
22

An Slfn2 mutation causes lymphoid and myeloid immunodeficiency due to loss of immune cell quiescence.
Michael Berger, Philippe Krebs, Karine Crozat, Xiaohong Li, Ben A Croker, Owen M Siggs, Daniel Popkin, Xin Du, Brian R Lawson, Argyrios N Theofilopoulos,[...]. Nat Immunol 2010
62
22

GammaH2AX and cancer.
William M Bonner, Christophe E Redon, Jennifer S Dickey, Asako J Nakamura, Olga A Sedelnikova, Stéphanie Solier, Yves Pommier. Nat Rev Cancer 2008
22


PARP Inhibitors in Small-Cell Lung Cancer: Rational Combinations to Improve Responses.
Erik H Knelson, Shetal A Patel, Jacob M Sands. Cancers (Basel) 2021
10
22

Schlafen2 mutation unravels a role for chronic ER stress in the loss of T cell quiescence.
Ibrahim Omar, Antonio Lapenna, Leonor Cohen-Daniel, Boaz Tirosh, Michael Berger. Oncotarget 2016
11
22

Randomized, Double-Blind, Phase II Study of Temozolomide in Combination With Either Veliparib or Placebo in Patients With Relapsed-Sensitive or Refractory Small-Cell Lung Cancer.
M Catherine Pietanza, Saiama N Waqar, Lee M Krug, Afshin Dowlati, Christine L Hann, Alberto Chiappori, Taofeek K Owonikoko, Kaitlin M Woo, Robert J Cardnell, Junya Fujimoto,[...]. J Clin Oncol 2018
177
22

Dephosphorylation activates the interferon-stimulated Schlafen family member 11 in the DNA damage response.
Dane Malone, Rea M Lardelli, Manqing Li, Michael David. J Biol Chem 2019
11
22

The plasticity of DNA replication forks in response to clinically relevant genotoxic stress.
Matteo Berti, David Cortez, Massimo Lopes. Nat Rev Mol Cell Biol 2020
71
22

Schlafen-11 expression is associated with immune signatures and basal-like phenotype in breast cancer.
Edoardo Isnaldi, Domenico Ferraioli, Lorenzo Ferrando, Sylvain Brohée, Fabio Ferrando, Piero Fregatti, Davide Bedognetti, Alberto Ballestrero, Gabriele Zoppoli. Breast Cancer Res Treat 2019
13
22

SLFN11 Expression in Advanced Prostate Cancer and Response to Platinum-based Chemotherapy.
Vincenza Conteduca, Sheng-Yu Ku, Loredana Puca, Megan Slade, Luisa Fernandez, Judy Hess, Rohan Bareja, Panagiotis J Vlachostergios, Michael Sigouros, Juan Miguel Mosquera,[...]. Mol Cancer Ther 2020
28
22

Laying a trap to kill cancer cells: PARP inhibitors and their mechanisms of action.
Yves Pommier, Mark J O'Connor, Johann de Bono. Sci Transl Med 2016
352
22

Systematic identification of genomic markers of drug sensitivity in cancer cells.
Mathew J Garnett, Elena J Edelman, Sonja J Heidorn, Chris D Greenman, Anahita Dastur, King Wai Lau, Patricia Greninger, I Richard Thompson, Xi Luo, Jorge Soares,[...]. Nature 2012
22

The NCI-60 Methylome and Its Integration into CellMiner.
William C Reinhold, Sudhir Varma, Margot Sunshine, Vinodh Rajapakse, Augustin Luna, Kurt W Kohn, Holly Stevenson, Yonghong Wang, Holger Heyn, Vanesa Nogales,[...]. Cancer Res 2017
31
22

Replication stress and cancer.
Hélène Gaillard, Tatiana García-Muse, Andrés Aguilera. Nat Rev Cancer 2015
482
22

Nucleoside analogs: molecular mechanisms signaling cell death.
B Ewald, D Sampath, W Plunkett. Oncogene 2008
148
22

A mouse model of ATR-Seckel shows embryonic replicative stress and accelerated aging.
Matilde Murga, Samuel Bunting, Maria F Montaña, Rebeca Soria, Francisca Mulero, Marta Cañamero, Youngsoo Lee, Peter J McKinnon, Andre Nussenzweig, Oscar Fernandez-Capetillo. Nat Genet 2009
258
22

A wake-up call for cancer DNA damage: the role of Schlafen 11 (SLFN11) across multiple cancers.
Bingnan Zhang, Kavya Ramkumar, Robert John Cardnell, Carl Michael Gay, C Allison Stewart, Wei-Lien Wang, Junya Fujimoto, Ignacio I Wistuba, Lauren Averett Byers. Br J Cancer 2021
9
22

Novel and Highly Potent ATR Inhibitor M4344 Kills Cancer Cells With Replication Stress, and Enhances the Chemotherapeutic Activity of Widely Used DNA Damaging Agents.
Ukhyun Jo, Ilya S Senatorov, Astrid Zimmermann, Liton Kumar Saha, Yasuhisa Murai, Se Hyun Kim, Vinodh N Rajapakse, Fathi Elloumi, Nobuyuki Takahashi, Christopher W Schultz,[...]. Mol Cancer Ther 2021
14
22

Role of Schlafen 2 (SLFN2) in the generation of interferon alpha-induced growth inhibitory responses.
Efstratios Katsoulidis, Nathalie Carayol, Jennifer Woodard, Iwona Konieczna, Beata Majchrzak-Kita, Alison Jordan, Antonella Sassano, Elizabeth A Eklund, Eleanor N Fish, Leonidas C Platanias. J Biol Chem 2009
54
22


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.